Partnering with Baxter to provide life-saving and -sustaining products and therapies globally.
Together with our partners and suppliers, we work to provide innovative life-saving and -sustaining products and therapies to patients and healthcare providers around the world.
We are committed to continually finding new ways to improve our environmental performance and promote supplier diversity, all while nurturing innovation to address the unmet healthcare needs of patients today and for decades to come.
We consider several environmental and social factors as we integrate sustainable practices into our procurement processes. We collaborate with our suppliers to identify opportunities to improve environmental performance, such as reducing energy use, greenhouse gas emissions and waste. We also promote human rights throughout our supplier base and seek to maximize procurement opportunities from small, minority, women, LGBT, disabled and veteran business enterprises by proactively identifying qualified suppliers.
We consider price, quality, environmental criteria and other factors when selecting and evaluating our suppliers. We do this with the intent to develop sustainable growth plans and build sound partnerships within all areas of our supply chain.
The automation of business transactions can help enable savings, efficiencies and accuracy across the revenue cycle. We support both Electronic Data Interchange (EDI), for direct connection between provider and supplier, and Internet-commerce, which connects buyers and sellers via a common technology platform to place orders and receive invoices online. We are also part of the Global Healthcare Exchange (GHX), the first Internet (supplier) exchange for the healthcare industry.
BioPharma Solutions Business
Through our contract manufacturing business, we work with pharmaceutical companies to support their commercialization objectives by providing scientific expertise, sterile contract manufacturing solutions, parenteral delivery systems and customized support services needed to meet the unique challenges that parenteral products face.